Seelos Therapeutics, Inc. (SEEL) Social Stream



Seelos Therapeutics, Inc. (SEEL): $0.59

-0.03 (-4.80%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add SEEL to Watchlist
Sign Up

Industry: Biotech


Ranked

of 392

in industry

Seelos Therapeutics Inc (SEEL) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering SEEL.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-30 6 $14 $6 $9.5 $0.925 927.03%
2022-01-21 6 $14 $5 $7.833 $0.925 746.81%
2022-03-08 5 $14 $3 $7.4 $0.925 700%
2022-03-11 4 $8 $3 $5.25 $0.925 467.57%

The Trend in the Analyst Price Target


SEEL's average price target has moved down $2.75 over the prior 14 months.

Over the past 48 weeks, SEEL's average upside potential has been 323.6%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-04-10 1 15 6.0 11.75 5.450 115.6%
2021-05-08 1 15 6.0 11.75 5.365 119.01%
2021-06-13 4 15 4.0 9.75 3.360 190.18%
2021-09-04 5 14 2.5 8.58 2.150 299.07%
2022-01-21 6 14 5.0 7.80 1.180 561.02%

SEEL Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 4 0 0 0 0 4

The Trend in the Broker Recommendations


Over the past 59 days, SEEL's average broker recommendation rating improved by 0.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • Seelos Therapeutics Inc's upside potential (average analyst target price relative to current price) is higher than 488.99% of all US stocks.
  • In the context of all US stocks, Seelos Therapeutics Inc's average analyst price target is higher than 29.41% of them.
  • In terms of how Seelos Therapeutics Inc fares relative to all US stocks, note that its variance in analysts' estimates is lower than -366.16% of that group.
  • In the context of stocks in the small market cap category, Seelos Therapeutics Inc's number of analysts covering the stock is higher than 327.76% of them.

Stocks similar to Seelos Therapeutics Inc in the Pharmaceutical Products industry regarding analyst recommendations and price targets are SBTX, RYTM, and RXDX.

Make investment decisions regarding SEEL using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.8026 seconds.